DR. ROBERT BLAINE LEHR M.D. NPI 1619901634

NPI Details

DR. Robert Blaine Lehr, M.D. is a specialist in Oklahoma City, OK with 31 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Robert Blaine Lehr, M.D. NPI is 1619901634. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Graduation Year:1995

The provider's business location address is:

2743 NW EXPRESSWAY
OKLAHOMA CITY, OK
ZIP 73112-047
Phone: (405) 951-4949
Fax: (405) 951-4005

The NPI 1619901634 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tildrakizumab, 1 mg (HCPCS:J3245)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Application of ultraviolet light to skin (HCPCS:96900)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:17280)
• Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11301)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:11310)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11311)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:11306)
• Shaving of skin growth of body, arms, or legs, 0.5 cm or less (HCPCS:11300)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:11305)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:17270)
• Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11302)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less (HCPCS:17260)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less (HCPCS:12031)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11401)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11307)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11312)
• Complicated or multiple drainage of skin abscess (HCPCS:10061)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm (HCPCS:12052)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 7/10/2006 and was last updated on 7/21/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: